MedPath
HSA Approval

HYMPAVZI SOLUTION FOR INJECTION IN SINGLE-DOSE PRE-FILLED PEN 150 MG/ML

SIN17187P

HYMPAVZI SOLUTION FOR INJECTION IN SINGLE-DOSE PRE-FILLED PEN 150 MG/ML

HYMPAVZI SOLUTION FOR INJECTION IN SINGLE-DOSE PRE-FILLED PEN 150 MG/ML

February 27, 2025

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS

Medical Information

Pending

Manufacturer Information

PFIZER PRIVATE LIMITED

Pfizer Manufacturing Belgium NV

Active Ingredients

Marstacimab

150 mg/ml

Marstacimab

Documents

Package Inserts

Marstacimab PI February 2025.pdf

Approved: February 27, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYMPAVZI SOLUTION FOR INJECTION IN SINGLE-DOSE PRE-FILLED PEN 150 MG/ML - HSA Approval | MedPath